September 19, 2016
The MIDC is pleased to announce Steve Dubin was recently appointed as Chair of the MIDC. Steve succeeds Rob Frier, President of MET Labs who served as Chair for the past 2 ½ years.
“My term as the Chairman of the MIDC was the culmination of many years on the MIDC board and working with Israeli companies in Maryland. I was constantly impressed by the efforts of Barry Bogage and the professional staff to find just the right contacts to bridge that connection between Israel and Maryland. I continue to be heartened that the MIDC is an unparalleled forum to bring together serious people of all religious and political stripes with the common goal of promoting commerce on both sides of the pond. I wish to thank Steve Dubin for stepping up to lead the agency and I am committed to helping in any way that I can”, said Rob Frier.
“I am excited to be chairing the board of MIDC and continuing the great work carried on by Rob Frier. Rob’s commitment to the MIDC, and his leadership in board development and program support sets a high bar for me and future MIDC Chairs. MIDC is a great organization doing important work with an impressive track record of creating jobs in Maryland. My goal is to help to build on that success while looking for additional innovative programs to help Israeli entrepreneurs succeed in bringing their businesses to, and expanding in, Maryland”, stated Steve Dubin.
Steve Dubin’s Bio:
Mr. Dubin is a Principal in SDA Ventures LLC, a firm focused on assisting emerging growth, middle-market and multi-national companies, primarily in the health & wellness, nutritional products and food services markets, on matters including corporate development, business acquisition, customer relations, growth strategies and corporate finance. Mr. Dubin is the Chairman of Enzymotec Ltd (Nasdaq:ENZY), a leading global supplier of specialty lipid-based products and solutions. Enzymotec develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies. Mr. Dubin, in conjunction with SDA Ventures, LLC, is a Senior Advisor to Paine & Partners, LLC, a global private equity investment firm located in New York, Chicago, and San Francisco, for the purpose of working with Paine to identify and execute investment opportunities in the global human and animal food and nutritional products industries. In addition, Mr. Dubin is a member of the board of Alcresta, Inc.
Prior to his co-founding of SDA Ventures in 2011, Mr. Dubin served as the CEO of Martek Biosciences Corporation (NASDAQ: MATK), a leader in the innovation, development, production and sale of high-value products from microbial sources that promote health and wellness through nutrition. Mr. Dubin played a key role in developing Martek’s business from an R&D company to a fully integrated, profitable, commercial organization with over $470 million in annual sales. He served in a variety of positions with Martek over the 14 years before his election as CEO in July 2006, including President, CFO, Treasurer, Secretary, General Counsel and Senior VP of Business Development. He also led Martek’s initial round of institutional financing in 1986. Mr. Dubin’s other experience includes working with and financing a variety of early-stage technology companies and spending 12 years in various positions at Suburban Bank, now part of Bank of America, including Vice President and Treasurer of its venture capital subsidiary.
Mr. Dubin graduated from the University of Maryland, College Park in 1974, where he studied business and accounting. He received his Juris Doctor Degree in 1980 from the National Law Center at the George Washington University in Washington, D.C. Mr. Dubin is a licensed CPA and a member of the Maryland Bar. In addition to serving as the Chair of the Board of the Maryland/Israel Development Center, he also serves on the Board of Visitors of the University of Maryland Children’s Hospital.